Remove Doctors Remove Hospitals Remove Vaccine
article thumbnail

Q&A: One scientist’s bold vision to make on-demand treatments routine for life-threatening rare genetic diseases

Broad Institute

was led by physician-scientists Kiran Musunuru and Rebecca Ahrens-Nicklas at the Children’s Hospital of Philadelphia and U. While doctors are cautious about using the word "cure" so early, it is a triumph for K.J.'s The team that treated K.J. Some of these treatments, like K.J.’s, s family and for everyone involved.

Treatment 133
article thumbnail

The Uncertain Origins of Aspirin

Codon

If a drug manufacturer were able to create a better alternative, patients and doctors would be grateful, and it would likely be extremely successful. He tested the drug on himself, then enlisted the help of doctors to test 100 grams of homemade acetylsalicylic acid. With their synthesis of aspirin, chemists at Bayer did exactly that.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

mRNA vaccines slash risk of COVID-19 infection by 91% in fully vaccinated people

The Pharma Data

People who receive mRNA COVID-19 vaccines are up to 91 percent less likely to develop the disease than those who are unvaccinated, according to a new nationwide study of eight sites, including Salt Lake City. Those who unfortunately got COVID-19 despite being vaccinated were still better off than those who didn’t.”

Vaccine 52
article thumbnail

Answering Your Qs on the New COVID Vaccines

The Pharma Data

11, 2021 — As the rollout of the COVID-19 vaccines continues, scores of questions are emerging. How do the COVID-19 vaccines work? The COVID-19 vaccines work by teaching the immune system to protect against the virus, experts said. ” Can the vaccines make you sick? Once vaccinated, can I get rid of the masks?

Vaccine 52
article thumbnail

COVID-19 Vaccine Developers Adjust Phase 3 Trial Protocols to Allow Authorized Vaccines | 2020-12-17

The Pharma Data

COVID-19 vaccine developers are faced with an ethical quandary — whether to let phase 3 trial participants become “unblinded” and to receive authorized vaccines as they become available, which could hinder the collection of meaningful trial data. Pfizer, which has received emergency approvals in the U.S.

Vaccine 52
article thumbnail

F. William Studier receives the 2024 Merkin Prize in ceremony at the Broad Institute for developing technology used to produce millions of doses of COVID-19 vaccines

Broad Institute

William Studier receives the 2024 Merkin Prize in ceremony at the Broad Institute for developing technology used to produce millions of doses of COVID-19 vaccines By Corie Lok October 16, 2024 Breadcrumb Home F. His T7 expression technology can be used to make large quantities of nearly any RNA or protein.

Vaccine 64
article thumbnail

Annaliesa Anderson, Ph.D., Will Lead Pfizer’s Vaccine Research & Development 

The Pharma Data

has been appointed Senior Vice President and Head of the Company’s Vaccine Research & Development (R&D) organization effective August 1, succeeding Kathrin U. Anderson most recently served as Vice President and Chief Scientific Officer for Bacterial Research and Hospital within the Vaccine R&D organization.

Vaccine 40